Japan Biotechno Pharma Co., Ltd.

Sitemap 日本語

About Japan Biotechno Pharma

CEO Message

Naoki Shinohara, CEO

Japan Biotechno Pharma was founded in August 2016 for brighter future of patients and families.
Our ambition is to contribute for society and healthcare through useful antibody technology.

The cost of social security continues to rise in Japan.
In particular, with the graying of society, the increase in the population requiring nursing care and the sophistication of medical technology, healthcare costs and economic loads are expected to heavily burden not only the working generation but the next generation as well.

What can we do?
How can we help save as many patients - and their families - as possible?
These were our thoughts behind the founding of this company.

I was involved in the pharmaceutical industry for 28 years at a foreign-affiliated pharmaceutical company before establishing this company.
I am committed to giving my utmost to be of service to healthcare and society in japan.

We have faith in the outcome of our dream and convictions.

It would be great if you could look forward to seeing what we achieve.

Naoki Shinohara, CEO

Corporate Philosophy

Japan Biotechno Pharma engages in its business activities with the aim of contributing to the creation of a richer social environment and the realization of brighter future for patients and their families through beneficial antibody technology.

Corporate Outline

Japan Biotechno Pharma Co., Ltd.
August 8, 2016
90 million yen
Naoki Shinohara, CEO
Naoki Shinohara, Director
Noboru Motomura, Director
Head Office
Yamasan Bldg., 2-6-13 Nihonbashi Honcho, Chuo-ku, Tokyo
Branch Office
Kobe Branch Office: Foundation for Biomedical Research and Innovation Bldg., 1-6-5 Minatojima Minami-machi, Chuo-ku, Kobe
Description of Business
Manufacturing, import, development and sale of pharmaceutical drugs
Founded on August 8, 2016, in Chuo-ku, Tokyo

Map to Head Office

Map to Kobe Branch Office


No current openings

Corporate Social Responsibility

Japan Biotechno Pharma address unmet medical needs through useful antibody technology so as to close the gaps of medical care in our social environment. We contribute to ensuring that as many people as possible will be able to engage healthily in their social activities.